Public Invited to Cancer Research Funding Discussions
Published Date: 1/28/2026
Notice
Summary
The National Cancer Institute is holding a public meeting on June 29-30, 2026, to discuss cancer research updates and review grant applications. Anyone interested can join in person or online, but part of the meeting will be private to protect sensitive information. This is a great chance for researchers and the public to stay in the loop about important cancer research decisions and funding.
Analyzed Economic Effects
5 provisions identified: 3 benefits, 2 costs, 0 mixed.
Public meeting: in-person and virtual
The National Cancer Advisory Board will hold a public meeting on June 29, 2026 (6:00 p.m. to 9:00 p.m.) and June 30, 2026 (9:00 a.m. to 4:00 p.m.). You can attend in person at listed Maryland locations or view the meeting online via the NIH Videocast at http://videocast.nih.gov/.
Closed session for grant review
A portion of the meeting on June 30, 2026 from 4:00 p.m. to 5:00 p.m. will be closed to the public to review and evaluate grant applications to protect confidential trade secrets, commercial property, and personal information.
On-site entry security requirements
If you plan to attend in person at the NCI-Shady Grove campus, you must show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and state the purpose of your visit due to instituted security procedures.
Opportunity to file written comments
Anyone may file written comments with the committee by sending a statement to the listed Contact Person; the statement should include your name, address, telephone number, and, if applicable, business or professional affiliation.
Accommodations for virtual viewers
If you plan to view the virtual meeting and need special assistance or other reasonable accommodations, you should notify the listed Contact Person in advance of the meeting.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2026-01694, Information Collection Being Submitted for Review and Approval to Office of Management and Budget
The Federal Communications Commission (FCC) is asking the public and other agencies to review and comment on their paperwork rules by February 27, 2026. They want to make it easier for small businesses with fewer than 25 employees to handle these forms. This review helps reduce unnecessary paperwork and keeps the process smooth and fair for everyone involved.
Next: 2026-01701, National Institute on Alcohol Abuse and Alcoholism; Amended Notice of Meeting
Heads up! The National Institute on Alcohol Abuse and Alcoholism changed the meeting times for their big February 5, 2026, gathering in Bethesda. The closed session now runs from 1:00 to 2:00 p.m., and the open session follows from 2:30 to 4:30 p.m. This tweak affects anyone interested in the meeting schedule but doesn’t change any funding or deadlines.